Literature DB >> 6391152

Calcium-channel blockers and the gastrointestinal tract. American College of Gastroenterology's Committee on FDA related matters.

M Traube, R W McCallum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6391152

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  12 in total

Review 1.  An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm.

Authors:  T P Short; E Thomas
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

2.  Comparative studies of AJG049, a novel Ca2+ channel antagonist, on voltage-dependent L-type Ca2+ currents in intestinal and vascular smooth muscle.

Authors:  M Hashimoto; N Teramoto; H-L Zhu; K Takahashi; Y Ito
Journal:  Br J Pharmacol       Date:  2006-08-14       Impact factor: 8.739

3.  On drugs and dilators for achalasia.

Authors:  M Traube
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

Review 4.  A rational clinical approach to esophageal motor disorders.

Authors:  J A DiPalma; G W Meyer
Journal:  Dysphagia       Date:  1987       Impact factor: 3.438

5.  Antioxidant effect of T-type calcium channel blockers in gastric injury.

Authors:  Dilek Bilici; Z Nur Banoğlu; Ahmet Kiziltunç; Bahattin Avci; Akif Ciftçioğlu; Sefa Bilici
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Prostaglandins and sulfhydryls may mediate gastric protection induced by verapamil in rats.

Authors:  C A Gutiérrez-Cabano
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

7.  Effects of verapamil and diltiazem on gastric emptying in normal subjects.

Authors:  R T Yavorski; S E Hallgren; P W Blue
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

8.  Constipation in adults: diagnosis and management.

Authors:  Vanessa C Costilla; Amy E Foxx-Orenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

9.  Selectivity of Ca2+ channel blockers in inhibiting muscular and nerve activities in isolated colon.

Authors:  S Lecchini; M Marcoli; F De Ponti; C A Castelletti; G M Frigo
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Nimodipine: evidence for clinically significant gastrointestinal side-effects.

Authors:  E Hund; A Aschoff; V Tronnier; J Hampl; S Kunze
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.